CV9202 is an RNActive-based vaccine that encodes six NSCLC TAAs (NY-ESO-1, MAGE-C1, MAGE-C2, 5T4, survivin, and MUC-1). The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.